Vyne Therapeutics Inc.
13F holders, Q1 2026 (March 31)1holders −1
0new positions
1sold out
$0.60avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Vyne Therapeutics Inc. in their 13F filings, down 1 from Q4 2025. 0 opened new positions and 1 sold out. The largest holder was Staley Capital Advisers Inc. ($31K).
- Company
- Vyne Therapeutics Inc.
- CUSIP
- 92941V209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $9 |
All 13F filers, Q4 2025 → Q1 2026: 16 shares sold, net −16 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Staley Capital Advisers Inc. | 0.00% | No change | 51,472 | $31K |
"% of holder's portfolio" is VYNE THERAPEUTICS INC's weight in each manager's 13F, not the share of Vyne Therapeutics Inc. the manager owns.